Identification of structural traits that increase the antimicrobial activity of a chimeric peptide of human β-defensins 2 and 3

Biochemical and Biophysical Research Communications

Volumn 427, Issue 1, 2012, Pages 207-211

  Spudy, Björn ^a   Sönnichsen, Frank D ^a   Waetzig, Georg H ^b   Grötzinger, Joachim ^a   Jung, Sascha ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b CONARIS Research Institute AG ^*  (Germany)

Author keywords

Antimicrobial activity; Antimicrobial peptide; Human beta defensin; NMR; Structure

Indexed keywords

BETA DEFENSIN 2; BETA DEFENSIN 3;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CHIMERA; DRUG EFFICACY; DRUG IDENTIFICATION; ESCHERICHIA COLI; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; BETA-DEFENSINS; CIRCULAR DICHROISM; ESCHERICHIA COLI; HUMANS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDES; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; STAPHYLOCOCCUS AUREUS;

ESCHERICHIA COLI; STAPHYLOCOCCUS AUREUS;

EID: 84867658679     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.09.052     Document Type: Article

References (32)

1. Jenssen H., Hamill P., Hancock R.E. Peptide antimicrobial agents. Clin. Microbiol. Rev. 2006, 19:491-511.
2. Izadpanah A., Gallo R.L. Antimicrobial peptides. J. Am. Acad. Dermatol. 2005, 52:381-390. (quiz 391-382).
3. Harder J., Glaser R., Schröder J.M. Human antimicrobial proteins effectors of innate immunity. J. Endotoxin Res. 2007, 13:317-338.
4. Pazgier M., Hoover D.M., Yang D., Lu W., Lubkowski J. Human beta-defensins. Cell. Mol. Life Sci. 2006, 63:1294-1313.
5. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 2003, 3:710-720.
6. Harder J., Bartels J., Christophers E., Schröder J.M. A peptide antibiotic from human skin. Nature 1997, 387:861.
7. Harder J., Bartels J., Christophers E., Schröder J.M. Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 2001, 276:5707-5713.
8. Lehrer R.I., Ganz T. Endogenous vertebrate antibiotics. Defensins, protegrins, and other cysteine-rich antimicrobial peptides. Ann. N. Y. Acad. Sci. 1996, 797:228-239.
9. Harder J., Meyer-Hoffert U., Teran L.M., Schwichtenberg L., Bartels J., Maune S., Schröder J.M. Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia. Am. J. Respir. Cell Mol. Biol. 2000, 22:714-721.
10. Jia H.P., Schutte B.C., Schudy A., Linzmeier R., Guthmiller J.M., Johnson G.K., Tack B.F., Mitros J.P., Rosenthal A., Ganz T., McCray P.B. Discovery of new human beta-defensins using a genomics-based approach. Gene 2001, 263:211-218.
11. Schröder J.M. Epithelial antimicrobial peptides: innate local host response elements. Cell. Mol. Life Sci. 1999, 56:32-46.
12. Hoover D.M., Rajashankar K.R., Blumenthal R., Puri A., Oppenheim J.J., Chertov O., Lubkowski J. The structure of human beta-defensin-2 shows evidence of higher order oligomerization. J. Biol. Chem. 2000, 275:32911-32918.
13. Schibli D.J., Hunter H.N., Aseyev V., Starner T.D., Wiencek J.M., McCray P.B., Tack B.F., Vogel H.J. The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus. J. Biol. Chem. 2002, 277:8279-8289.
14. Garcia J.R., Jaumann F., Schulz S., Krause A., Rodriguez-Jimenez J., Forssmann U., Adermann K., Kluver E., Vogelmeier C., Becker D., Hedrich R., Forssmann W.G., Bals R. Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res. 2001, 306:257-264.
15. Jung S., Mysliwy J., Spudy B., Lorenzen I., Reiss K., Gelhaus C., Podschun R., Leippe M., Grötzinger J. Human beta-defensin 2 and beta-defensin 3 chimeric peptides reveal the structural basis of the pathogen specificity of their parent molecules. Antimicrob. Agents Chemother. 2011, 55:954-960.
16. Chen G.C., Yang J.T. Two-point calibration of circulardichrometer with d-10-camphorsulfonic acid. Anal. Lett. 1977, 10:1195-1207.
17. Pick U. Liposomes with a large trapping capacity prepared by freezing and thawing of sonicated phospholipid mixtures. Arch. Biochem. Biophys. 1981, 212:186-194.
18. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 1995, 6:277-293.
19. Johnson B.A. Using NMRView to visualize and analyze the NMR spectra of macromolecules. Methods Mol. Biol. 2004, 278:313-352.
20. Güntert P. Automated NMR structure calculation with CYANA. Methods Mol. Biol. 2004, 278:353-378.
21. Vriend G. WHAT IF: a molecular modeling and drug design program. J. Mol. Graphics 1990, 8:52-56. (29).
22. van Gunsteren W.F., Billeter S.R., Eising A.A., Hünenberger P.H., Krüger P., Mark A.E., Scott W.R.P., Tironi I.G. Biomolecular Simulation: The GROMOS96 Manual and User Guide, vdf Hochschulverlag AG an der ETH Zürich. Zürich 1996, 1-1042.
23. Koradi R., Billeter M., Wüthrich K. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graphics 1996, 14:51-55. (29-32).
24. Petrey D., Honig B. GRASP2: visualization, surface properties, and electrostatics of macromolecular structures and sequences. Methods Enzymol. 2003, 374:492-509.
25. Klüver E., Adermann K., Schulz A. Synthesis and structure-activity relationship of beta-defensins, multi-functional peptides of the immune system. J. Pept. Sci. 2006, 12:243-257.
26. Sawai M.V., Jia H.P., Liu L., Aseyev V., Wiencek J.M., McCray P.B., Ganz T., Kearney W.R., Tack B.F. The NMR structure of human beta-defensin-2 reveals a novel alpha-helical segment. Biochemistry 2001, 40:3810-3816.
27. Taylor K., Clarke D.J., McCullough B., Chin W., Seo E., Yang D., Oppenheim J., Uhrin D., Govan J.R., Campopiano D.J., MacMillan D., Barran P., Dorin J.R. Analysis and separation of residues important for the chemoattractant and antimicrobial activities of beta-defensin 3. J. Biol. Chem. 2008, 283:6631-6639.
28. Liu S., Zhou L., Li J., Suresh A., Verma C., Foo Y.H., Yap E.P., Tan D.T., Beuerman R.W. Linear analogues of human beta-defensin 3: concepts for design of antimicrobial peptides with reduced cytotoxicity to mammalian cells. Chem. BioChem 2008, 9:964-973.
29. Röhrl J., Yang D., Oppenheim J.J., Hehlgans T. Human beta-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2. J. Immunol. 2010, 184:6688-6694.
30. Selsted M.E., Ouellette A.J. Mammalian defensins in the antimicrobial immune response. Nat. Immunol. 2005, 6:551-557.
31. Klüver E., Schulz-Maronde S., Scheid S., Meyer B., Forssmann W.G., Adermann K. Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity. Biochemistry 2005, 44:9804-9816.
32. Bai Y., Liu S., Jiang P., Zhou L., Li J., Tang C., Verma C., Mu Y., Beuerman R.W., Pervushin K. Structure-dependent charge density as a determinant of antimicrobial activity of peptide analogues of defensin. Biochemistry 2009, 48:7229-7239.